niacinamide and Hepatitis B studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research Excerpts

Excerpt	Relevance	Reference
"Patients with advanced hepatocellular carcinoma (HCC) received sorafenib at a dose of 400 mg twice daily in 4-week cycles."	9.14	Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response. ( Chan, P; Cheung, TT; Chok, SH; Fan, ST; Ng, KK; Poon, RT; Yau, T, 2009)
"We report the outcomes of sorafenib therapy for advanced hepatocellular carcinoma (HCC) in our Department."	7.88	The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy. ( Arakawa, Y; Bando, Y; Ikemoto, T; Imura, S; Ishikawa, D; Iwahashi, S; Morine, Y; Saito, YU; Shimada, M; Takasu, C; Teraoku, H; Yoshimoto, T, 2018)
"Although sorafenib is the only available drug with proven efficacy for patients with advanced hepatocellular carcinoma (HCC), the clinical efficacy of sorafenib is variable and unpredictable."	7.85	Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib. ( Cheong, JY; Cho, HJ; Cho, SW; Hwang, JC; Kang, DR; Kim, B; Kim, JK; Kim, SS; Lee, JH; Lee, KJ; Lee, KM; Lim, SG; Nam, JS; Oh, MJ; Shin, SJ; Yang, MJ; Yoo, BM, 2017)
"Liver resection combined with postoperative sorafenib to prevent recurrence remains a controversial approach for cases of hepatocellular carcinoma (HCC), especially cases with a high risk of recurrence."	7.83	Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence. ( Hao, J; Lei, J; Li, B; Liu, Z; Wang, W; Wen, T; Wu, L; Yan, L; Zeng, Y; Zhang, P; Zhong, J; Zhu, J, 2016)
" There is a lack of evidence about the prognostic value of serum LDH level in patients with hepatocellular carcinoma (HCC) receiving sorafenib treatment from hepatitis B virus endemic areas."	7.83	Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area. ( Bi, XY; Cai, JQ; Han, Y; Huang, Z; Li, H; Li, MX; Li, ZY; Yao, XS; Zhang, YF; Zhao, DB; Zhao, H; Zhao, JJ; Zhou, JG, 2016)
"To evaluate the role of antiviral therapy with nucleoside analogs (NAs) in sorafenib-treated patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)."	7.81	Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib. ( Chen, M; Gao, H; Huang, J; Li, S; Wang, H; Xu, L; Zhang, Y; Zhou, Z, 2015)
"Sorafenib (SO) was the first systemic agent to demonstrate a significant improvement in overall survival in patients with advanced hepatocellular carcinoma (HCC); international guidelines now recommend SO as a first-line treatment in patients with unresectable HCC who are not eligible for locoregional therapies and maintain preserved liver function."	7.79	Selection and management of hepatocellular carcinoma patients with sorafenib: recommendations and opinions from an Italian liver unit. ( D'Angelo, S; De Cristofano, R; Secondulfo, M; Sorrentino, P, 2013)
"This study was conducted to assess the efficacy and safety of sorafenib monotherapy in clinical practice settings for Korean patients with hepatocellular carcinoma (HCC) related primarily to HBV infection."	7.75	Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area. ( Choi, JI; Kim, CM; Park, BJ; Park, JW; Shim, JH, 2009)
"Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) shows a higher incidence in men, mainly because of hepatitis B X (HBx)-mediated enhancement of androgen receptor (AR) activity."	5.42	Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver through SHP-1. ( Chen, DS; Chen, KF; Chen, PJ; Lin, WH; Shiau, CW; Teng, YC; Tsai, TF; Wang, SH; Yeh, SH, 2015)
"Sorafenib (SO) has proven efficacy in prolonging survival in patients with advanced HCC."	5.39	Sorafenib and entecavir: the dioscuri of treatment for advanced hepatocellular carcinoma? ( D'Angelo, S; De Cristofano, R; Secondulfo, M; Sorrentino, P, 2013)
"Patients with advanced hepatocellular carcinoma (HCC) received sorafenib at a dose of 400 mg twice daily in 4-week cycles."	5.14	Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response. ( Chan, P; Cheung, TT; Chok, SH; Fan, ST; Ng, KK; Poon, RT; Yau, T, 2009)
"We report the outcomes of sorafenib therapy for advanced hepatocellular carcinoma (HCC) in our Department."	3.88	The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy. ( Arakawa, Y; Bando, Y; Ikemoto, T; Imura, S; Ishikawa, D; Iwahashi, S; Morine, Y; Saito, YU; Shimada, M; Takasu, C; Teraoku, H; Yoshimoto, T, 2018)
"Although sorafenib is the only available drug with proven efficacy for patients with advanced hepatocellular carcinoma (HCC), the clinical efficacy of sorafenib is variable and unpredictable."	3.85	Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib. ( Cheong, JY; Cho, HJ; Cho, SW; Hwang, JC; Kang, DR; Kim, B; Kim, JK; Kim, SS; Lee, JH; Lee, KJ; Lee, KM; Lim, SG; Nam, JS; Oh, MJ; Shin, SJ; Yang, MJ; Yoo, BM, 2017)
"Liver resection combined with postoperative sorafenib to prevent recurrence remains a controversial approach for cases of hepatocellular carcinoma (HCC), especially cases with a high risk of recurrence."	3.83	Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence. ( Hao, J; Lei, J; Li, B; Liu, Z; Wang, W; Wen, T; Wu, L; Yan, L; Zeng, Y; Zhang, P; Zhong, J; Zhu, J, 2016)
" There is a lack of evidence about the prognostic value of serum LDH level in patients with hepatocellular carcinoma (HCC) receiving sorafenib treatment from hepatitis B virus endemic areas."	3.83	Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area. ( Bi, XY; Cai, JQ; Han, Y; Huang, Z; Li, H; Li, MX; Li, ZY; Yao, XS; Zhang, YF; Zhao, DB; Zhao, H; Zhao, JJ; Zhou, JG, 2016)
"To evaluate the role of antiviral therapy with nucleoside analogs (NAs) in sorafenib-treated patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)."	3.81	Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib. ( Chen, M; Gao, H; Huang, J; Li, S; Wang, H; Xu, L; Zhang, Y; Zhou, Z, 2015)
"Sorafenib (SO) was the first systemic agent to demonstrate a significant improvement in overall survival in patients with advanced hepatocellular carcinoma (HCC); international guidelines now recommend SO as a first-line treatment in patients with unresectable HCC who are not eligible for locoregional therapies and maintain preserved liver function."	3.79	Selection and management of hepatocellular carcinoma patients with sorafenib: recommendations and opinions from an Italian liver unit. ( D'Angelo, S; De Cristofano, R; Secondulfo, M; Sorrentino, P, 2013)
"This study was conducted to assess the efficacy and safety of sorafenib monotherapy in clinical practice settings for Korean patients with hepatocellular carcinoma (HCC) related primarily to HBV infection."	3.75	Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area. ( Choi, JI; Kim, CM; Park, BJ; Park, JW; Shim, JH, 2009)
"Sorafenib, a multitargeted kinase inhibitor used for the treatment of unresectable hepatocellular carcinoma and advanced renal cell carcinomas, received FDA approval in 2005."	3.75	Localized dyskeratotic plaque with milia associated with sorafenib. ( Burkemper, NM; Chappell, JA; Semchyshyn, N, 2009)
"Their hematological malignancies were well-controlled at the time of liver resection."	1.46	Liver resection for hepatocellular carcinoma in patients with hematological malignancies. ( Cheng, SB; Huang, CC; Jan, YG; Lin, HC; Lin, YL; P'eng, FK; Shen, CH; Teng, CJ; Wu, CC; Yang, YS, 2017)
"Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) shows a higher incidence in men, mainly because of hepatitis B X (HBx)-mediated enhancement of androgen receptor (AR) activity."	1.42	Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver through SHP-1. ( Chen, DS; Chen, KF; Chen, PJ; Lin, WH; Shiau, CW; Teng, YC; Tsai, TF; Wang, SH; Yeh, SH, 2015)
"Sorafenib (SO) has proven efficacy in prolonging survival in patients with advanced HCC."	1.39	Sorafenib and entecavir: the dioscuri of treatment for advanced hepatocellular carcinoma? ( D'Angelo, S; De Cristofano, R; Secondulfo, M; Sorrentino, P, 2013)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (22.22)	29.6817
2010's	21 (77.78)	24.3611
2020's	0 (0.00)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
Randomized, Open-label and Multi-center Clinical Trial to Evaluate the Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced Hepatocellular Carcinoma[NCT01897610]	Phase 2	40 participants (Actual)	Interventional	2013-12-31	Completed
The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study[NCT01831037]		0 participants (Actual)	Observational	2015-07-31	Withdrawn (stopped due to Unable to obtain funding)
The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction in Patients With Korean Hepatocellular Carcinoma Patients: Multicenter, Prospective Randomized Double-Blind Controlled Study[NCT03212625]	Phase 4	288 participants (Actual)	Interventional	2016-01-28	Completed
Radiofrequency Ablation Combined With Highly-purified CTL vs. Radiofrequency Ablation Alone for Recurrent HCC[NCT02678013]	Phase 3	210 participants (Anticipated)	Interventional	2016-02-29	Active, not recruiting
Prophylactic Minimally-invasive Local Ablation Therapies for the Hepatic Dysplastic Nodules in Patients With Positive Hepatitis B Surface Antigen (HBsAg).[NCT02793791]		30 participants (Anticipated)	Interventional	2016-09-30	Not yet recruiting
The Combination of Pembrolizumab and Lenvatinib as Neoadjuvant Treatment for Hepatocellular Carcinoma Patients: a Single Arm Phase II Study[NCT05389527]	Phase 2	43 participants (Anticipated)	Interventional	2022-09-30	Active, not recruiting
A Real World Study of Regogfinib in the Treatment of Advanced Hepatocellular Carcinoma[NCT05557656]		800 participants (Anticipated)	Observational	2023-01-05	Not yet recruiting
Stereotactic Image-Guided Microwave Ablation for Hepatocellular Carcinoma - Does Computer-assistance Broaden Eligibility and Efficacy of Ablative Treatment?[NCT03630068]		87 participants (Actual)	Observational	2015-01-01	Completed
A New Track Ablation Device for Liver Biopsy: A Feasibility Study[NCT02521129]	Phase 1/Phase 2	20 participants (Anticipated)	Interventional	2015-09-30	Not yet recruiting
Transarterial Radioembolization Versus Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma[NCT02729506]	Phase 4	150 participants (Anticipated)	Interventional	2016-01-31	Recruiting
A Randomized Controlled Trial of Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma[NCT02243384]		150 participants (Actual)	Interventional	2014-09-01	Completed
Circulating Tumor Cells and Tumor DNA in HCC and NET - Patient-specific Biomarkers for Clinical Decision Support and Tailored Relapse Diagnostics[NCT02973204]		167 participants (Actual)	Observational [Patient Registry]	2016-11-30	Completed
A Prospective, US Multicenter Open Label Study in the Treatment of Hepatocellular Carcinoma (HCC) With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin[NCT03452553]		0 participants (Actual)	Interventional	2018-07-01	Withdrawn (stopped due to CMS disapproval, no alternative for sites/patient, risk of financial burden.)
Effectivity and Safety of Microwave Ablation Combined With Transcatheter Arterial Chemoembolization(TACE) for Huge Unresectable Hepatocellular Carcinoma: a Multicenter Analysis[NCT03277716]		100 participants (Anticipated)	Interventional	2017-12-01	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Management of hepatocellular carcinoma. Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:5 Topics: alpha-Fetoproteins; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Disease Mana	2015
Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: a meta-analysis of randomized clinical trials. Oncology, 2015, Volume: 88, Issue:6 Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Clinical Trials, Phase III as Topic; Hepatitis B;	2015
Bullous pemphigoid in a renal transplant recipient: a case report and review of the literature. American journal of clinical dermatology, 2009, Volume: 10, Issue:3 Topics: Administration, Cutaneous; Anti-Infective Agents; Clobetasol; Dapsone; Doxycycline; Fatal Outcome; G	2009
Current management of hepatocellular carcinoma. The Medical clinics of North America, 2009, Volume: 93, Issue:4 Topics: Algorithms; Benzenesulfonates; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Ther	2009

Article	Year
Liver resection for hepatocellular carcinoma in patients with hematological malignancies. World journal of surgical oncology, 2017, Nov-02, Volume: 15, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers; Carcinoma, Hepatocellul	2017
The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy. Anticancer research, 2018, Volume: 38, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Combined Modality	2018
Selection and management of hepatocellular carcinoma patients with sorafenib: recommendations and opinions from an Italian liver unit. Future oncology (London, England), 2013, Volume: 9, Issue:4 Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Diarrhea; Dose-Response Relationship, Drug;	2013
Sorafenib and entecavir: the dioscuri of treatment for advanced hepatocellular carcinoma? World journal of gastroenterology, 2013, Volume: 19, Issue:14 Topics: Aged; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis	2013
Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:6 Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Therapy, Co	2015
Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread. PloS one, 2015, Volume: 10, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Hepatitis B; Humans; Liver Ne	2015
Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver through SHP-1. Journal of the National Cancer Institute, 2015, Volume: 107, Issue:10 Topics: Age Factors; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Enzyme Activation; Gene Expr	2015
Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence. Oncotarget, 2016, Jul-05, Volume: 7, Issue:27 Topics: Adult; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Disease-Free Survival;	2016
Cost-effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; China; Cost-Benefit	2016
Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area. Oncotarget, 2016, Dec-27, Volume: 7, Issue:52 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Hepati	2016
Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib. Cytokine, 2017, Volume: 95 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Carcinoma, Hepatocellular; Cohort Studies; Cytokines	2017
[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008]. Orvosi hetilap, 2008, Jul-13, Volume: 149, Issue:28 Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Tria	2008
Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area. Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:4 Topics: Adult; Aged; Benzenesulfonates; Carcinoma, Hepatocellular; Disease Progression; Female; Hepatitis B;	2009
Localized dyskeratotic plaque with milia associated with sorafenib. Journal of drugs in dermatology : JDD, 2009, Volume: 8, Issue:6 Topics: Acantholysis; Benzenesulfonates; Carcinoma, Hepatocellular; Diabetes Mellitus; Drug Eruptions; Hepat	2009
Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinoma. Haemophilia : the official journal of the World Federation of Hemophilia, 2010, Volume: 16, Issue:1 Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chronic Disease; Factor V	2010
Drug therapy: sorafenib. Hepatology (Baltimore, Md.), 2010, Volume: 51, Issue:5 Topics: Aged; Benzenesulfonates; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis C; Humans; Liver Neoplasm	2010
Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report. Medical oncology (Northwood, London, England), 2011, Volume: 28 Suppl 1 Topics: Aged; Antiretroviral Therapy, Highly Active; Benzenesulfonates; Carcinoma, Hepatocellular; Coinfecti	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatitis B; Hepatitis	2011
Multidisciplinary management of nonresectable hepatocellular carcinoma. Oncology, 2011, Volume: 81 Suppl 1 Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic;	2011
Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hep	2012
MCM7 expression predicts post-operative prognosis for hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:10 Topics: Benzenesulfonates; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Line, Tum	2012
Clinicopathological characteristics of hepatocellular carcinoma in Turkey. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcoholism; alpha-Fetoproteins; Benzenesulfonates; Bioma	2012

niacinamide and Hepatitis B

Research Excerpts

Research

Studies (27)

Authors

Clinical Trials (14)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Lin, HC	1
Yang, YS	1
Teng, CJ	1
Shen, CH	1
Jan, YG	1
Cheng, SB	1
Wu, CC	1
Lin, YL	1
Huang, CC	1
P'eng, FK	1
Yoshimoto, T	1
Imura, S	1
Morine, Y	1
Ikemoto, T	1
Arakawa, Y	1
Iwahashi, S	1
Saito, YU	1
Takasu, C	1
Ishikawa, D	1
Teraoku, H	1
Bando, Y	1
Shimada, M	1
D'Angelo, S	2
Secondulfo, M	2
De Cristofano, R	2
Sorrentino, P	2
Fitzmorris, P	1
Shoreibah, M	1
Anand, BS	1
Singal, AK	1
Shao, YY	1
Shau, WY	1
Chan, SY	1
Lu, LC	1
Hsu, CH	1
Cheng, AL	1
Xu, L	1
Gao, H	1
Huang, J	1
Wang, H	1
Zhou, Z	1
Zhang, Y	1
Li, S	1
Chen, M	1
Sinn, DH	1
Cho, JY	1
Gwak, GY	1
Paik, YH	1
Choi, MS	1
Lee, JH	2
Koh, KC	1
Paik, SW	1
Yoo, BC	1
Wang, SH	1
Yeh, SH	1
Shiau, CW	1
Chen, KF	1
Lin, WH	1
Tsai, TF	1
Teng, YC	1
Chen, DS	1
Chen, PJ	1
Lei, J	1
Zhong, J	1
Hao, J	1
Liu, Z	1
Zhang, P	2
Wu, L	1
Yan, L	1
Zhu, J	1
Zeng, Y	1
Li, B	2
Wen, T	1
Wang, W	1
Yang, Y	1
Wen, F	1
Wheeler, J	1
Fu, P	1
Li, Q	1
Li, MX	1
Zhao, H	1
Bi, XY	1
Li, ZY	1
Yao, XS	1
Li, H	1
Huang, Z	1
Han, Y	1
Zhou, JG	1
Zhao, JJ	1
Zhang, YF	1
Zhao, DB	1
Cai, JQ	1
Cho, HJ	1
Kim, SS	1
Nam, JS	1
Oh, MJ	1
Kang, DR	1
Kim, JK	1
Kim, B	1
Yang, MJ	1
Hwang, JC	1
Lim, SG	1
Shin, SJ	1
Lee, KM	1
Yoo, BM	1
Lee, KJ	1
Cho, SW	1
Cheong, JY	1
Pár, A	1
Pár, G	1
Shim, JH	1
Park, JW	1
Choi, JI	1
Park, BJ	1
Kim, CM	1
Yau, T	1
Chan, P	1
Ng, KK	1
Chok, SH	1
Cheung, TT	1
Fan, ST	1
Poon, RT	1
Chen, TJ	1
Lai, PC	1
Yang, LC	1
Kuo, TT	1
Hong, HS	1
Chappell, JA	1
Burkemper, NM	1
Semchyshyn, N	1
Mendizabal, M	1
Reddy, KR	1
Lapecorella, M	1
Napolitano, M	1
Tudini, M	1
Bruera, G	1
Lucchesi, A	1
Giordano, AV	1
Mariani, G	1
Ricevuto, E	1
Finn, RS	1
Chelis, L	1
Ntinos, N	1
Souftas, V	1
Deftereos, S	1
Xenidis, N	1
Chamalidou, E	1
Maltezos, E	1
Kakolyris, S	1
Bruix, J	1
Sherman, M	1
Park, HC	1
Seong, J	2
Tanaka, M	1
Zeng, ZC	1
Lim, HY	1
Guan, S	1
Bae, SH	1
Tak, WY	1
Kim, BK	1
Kim, SU	1
Park, JY	1
Kim, DY	1
Ahn, SH	1
Park, MS	1
Kim, EH	1
Lee, DY	1
Han, KH	1
Zhou, YM	1
Zhang, XF	1
Cao, L	1
Sui, CJ	1
Li, YM	1
Yin, ZF	1
Dogan, E	1
Yalcin, S	1
Koca, D	1
Olmez, A	1